Progyny Inc (PGNY) financials

NASDAQ · Health Care

$29.19 +2.78% Close Oct 30, 2026 Live

Progyny revenue and earnings by year

Progyny's revenue was $1.29 billion in the fiscal year to December 31, 2025, up 10.4% from the year before. Net income was $58.5 million, 4.5% of revenue. Since the fiscal year to December 31, 2017, revenue has grown 50.6% a year on average.

RevenueNet income
$0$500M$1.00B
201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 9 fiscal years

In billions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue1.291.171.090.790.500.340.230.110.05
Revenue growth10.4%7.2%38.3%57.2%45.2%50.1%117.9%116.9%—
Gross profit0.300.250.240.170.110.070.050.020.01
Gross margin23.6%21.7%21.9%21.3%22.4%20.3%19.8%18.4%15.2%
Operating income0.090.070.060.020.030.010.01-0.00-0.01
Operating margin6.6%5.8%5.7%3.0%6.5%2.4%4.2%-3.3%-22.7%
Net income0.060.050.060.030.070.05-0.01-0.01-0.01
Net margin4.5%4.7%5.7%3.9%13.1%13.5%-3.7%-5.3%-25.6%
Diluted EPS$0.65$0.57$0.62$0.30$0.66$0.47———
Free cash flow0.190.170.190.080.020.04-0.000.00-0.01

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open PGNY in Markets.

How Progyny makes money

Revenue by segment in the quarter to June 30, 2026, as the company reports it.

SegmentRevenueShare
Fertility Benefit Services$230M65.7%
Pharmacy Benefit Services$120M34.3%

See also: PGNY valuation and P/E history · PGNY returns

No forecast, no recommendation. This page describes Progyny Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.